Close Menu

EFSA concludes – No consumer health risk from Bisphenol A exposure

EFSA concludes ‘No consumer health risk from bisphenol A exposure’
Today, the European Food Safety Authority (EFSA) published its final scientific opinion on the safety of
Bisphenol A (BPA). It combines the authority´s assessment of both exposure and health aspects and
considers comments received from national authorities and stakeholders following extensive engagement
and consultation. The new assessment covers exposure from food sources along with exposure from a
range of other potential sources, and considers all age groups of the population.
Exposure from all sources is very low and well below the new safe limit for all age groups
– BPA-based products safe for consumers
Applying a comprehensive weight-of-evidence approach to all relevant studies on BPA, and using a more
refined methodology, EFSA’s scientific experts set a lifetime safe intake level, known as the tolerable daily
intake (TDI). Notably, the safe level conservatively takes into account remaining uncertainties about
potential health effects of BPA. Considering all sources of exposure together, the expert panel concluded:
‘BPA poses no health risk to consumers of any age group’.
It is anticipated that EFSA will revisit the TDI, which is currently designated as temporary, to incorporate
the results of ongoing US governmental studies, which were designed to resolve remaining uncertainties
about the safety of BPA.
Transparent and open process strengthens the conclusion
The PC/BPA Group and Epoxy Resin Committee of PlasticsEurope appreciate the transparent and open
stakeholder engagement of EFSA during the public consultation. This process ensured that a wide range
of scientific views and information were considered and addressed in the scientific opinion.
Safety confirmation consistent with assessments of government bodies around the world
The EFSA conclusion is consistent with the recent clear statement confirming the safety of BPA in food
contact materials from the US Food and Drug Administration (FDA). Many other government bodies, for
example Health Canada, have also evaluated the scientific evidence on BPA and reached similar
In light of EFSA´s conclusions, the French restriction on BPA is disproportionate and
should be withdrawn
“The fact that any realistic exposure to BPA is well below even the conservative safety threshold
established by EFSA shows that blanket restrictions being applied at national level, in particular in France,
are unjustified and should be withdrawn,” says Jasmin Bird of the PC/BPA-group. “This EFSA conclusion
on BPA should be used as the basis for consistent and harmonised European food safety regulation, and
should be respected by all EU Member States.”

For more information please contact:
Jasmin Bird
PC/BPA-Group PlasticsEurope
website: Tel: +32 2 676 17 38
email: Fax: +32 2 675 39 35